• Profile
Close

Obesity and weight gain are associated with progression of fibrosis in patients with nonalcoholic fatty liver disease

Clinical Gastroenterology and Hepatology Feb 02, 2019

Kim Y, et al. - In young and middle-aged adults with nonalcoholic fatty liver disease (NAFLD), researchers assessed the association of weight change and baseline BMI with fibrosis progression, determined by non-invasive measurement of a marker. In this prospective cohort study, they included 40,700 adults with NAFLD in Korea who had regular health screening exams and were followed for a median 6.0 years. Based on aspartate aminotransferase to platelet ratio index, obesity and weight gain were independently correlated with increased risk of fibrosis progression. In individuals with NAFLD, sustaining a normal healthy weight and avoiding weight gain could help reduce fibrosis progression.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay